Income Statement Neurotech International Limited

Equities

NTI

AU000000NTI9

Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 12:10:17 2026-01-23 am EST			5-day change	1st Jan Change
0.0140 ^AUD	-6.67%		0.00%	-

Dec. 16	Neurotech International receives A$4 million placement commitments	RE
Dec. 14	Neurotech International requests trading halt pending capital raising announcement	RE

40e.oiT_PG8wrdzmlWeSB8y2D4wkDftC0S-mNWP8RscVr7g.kmGWdyNylKuQ11D4QLzCSN9pNYwFp13BdFefc51n2pXsUa9vDmH7u436Kg

Published financial data: NEUROTECH INTERNATIONAL LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	206K	38.26K	5.96K	1.96K	238
Other Revenues, Total	19.39K	569K	1.19M	3.18M	2.44M
Total Revenues	226K	608K	1.19M	3.18M	2.44M
Cost of Goods Sold, Total	-20.34K	34.05K	-	7.83K	-
Gross Profit	246K	574K	1.19M	3.17M	2.44M
Selling General & Admin Expenses, Total	2.31M	1.35M	2.58M	3.51M	3.59M
Provision for Bad Debts	-	-	-9.04K	-	-
R&D Expenses	5.36M	2.58M	6.45M	5.25M	9.94M
Depreciation & Amortization - (IS)	-	588	1.74K	583	289
Other Operating Expenses	3.12K	10.64K	21.54K	-358K	-353K
Other Operating Expenses, Total	7.67M	3.93M	9.05M	8.4M	13.18M
Operating Income	-7.43M	-3.36M	-7.85M	-5.23M	-10.74M
Interest Expense, Total	-1.71K	-1.37K	-	-	-
Interest And Investment Income	135	486	59.56K	158K	137K
Net Interest Expenses	-1.57K	-883	59.56K	158K	137K
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-7.43M	-3.36M	-7.79M	-5.07M	-10.6M
Asset Writedown	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-7.43M	-3.36M	-7.79M	-5.07M	-10.6M
Earnings From Continuing Operations	-7.43M	-3.36M	-7.79M	-5.07M	-10.6M
Net Income to Company	-7.43M	-3.36M	-7.79M	-5.07M	-10.6M
Net Income - (IS)	-7.43M	-3.36M	-7.79M	-5.07M	-10.6M
Net Income to Common Incl Extra Items	-7.43M	-3.36M	-7.79M	-5.07M	-10.6M
Net Income to Common Excl. Extra Items	-7.43M	-3.36M	-7.79M	-5.07M	-10.6M
Per Share Items
Net EPS - Basic	-0.02	-0	-0.01	-0.01	-0.01
Basic EPS - Continuing Operations	-0.02	-0	-0.01	-0.01	-0.01
Basic Weighted Average Shares Outstanding	493M	697M	799M	912M	1.04B
Net EPS - Diluted	-0.02	-0	-0.01	-0.01	-0.01
Diluted EPS - Continuing Operations	-0.02	-0	-0.01	-0.01	-0.01
Diluted Weighted Average Shares Outstanding	493M	697M	799M	912M	1.04B
Normalized Basic EPS	-0.01	-0	-0.01	-0	-0.01
Normalized Diluted EPS	-0.01	-0	-0.01	-0	-0.01
Supplemental Items
EBITDA	-	-3.36M	-7.85M	-5.23M	-10.74M
EBITA	-7.43M	-3.36M	-7.85M	-5.23M	-10.74M
EBIT	-7.43M	-3.36M	-7.85M	-5.23M	-10.74M
Normalized Net Income	-4.64M	-2.1M	-4.87M	-3.17M	-6.62M
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
Advertising Expense	12.51K	12.48K	10.93K	379	4.64K
Selling and Marketing Expenses	12.51K	12.48K	10.93K	379	4.64K
General and Administrative Expenses	670K	710K	949K	1.13M	1.21M
Research And Development Expense From Footnotes	5.36M	2.58M	6.45M	5.25M	9.94M
Stock-Based Comp., S&M Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	1.22M	83.96K	877K	1.81M	1.58M
Stock-Based Comp., Other (Total)	3.77M	-	-	375K	-
Total Stock-Based Compensation	4.99M	83.96K	877K	2.18M	1.58M

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	4.83M	1.9M	5.03M	11.63M	3.03M
Total Cash And Short Term Investments	4.83M	1.9M	5.03M	11.63M	3.03M
Accounts Receivable, Total	143K	-	-	-	-
Other Receivables	3	99.48K	258K	318K	88.7K
Notes Receivable	-	-	-	-	-
Total Receivables	143K	99.48K	258K	318K	88.7K
Inventory	-	7.2K	7.78K	-	-
Prepaid Expenses	35.65K	18.24K	16.82K	270K	121K
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	5.01M	2.02M	5.31M	12.21M	3.24M
Gross Property Plant And Equipment	-	3.2K	-	-	-
Accumulated Depreciation	-	-588	-	-	-
Net Property Plant And Equipment	-	2.62K	872	289	-
Other Intangibles, Total	-	-	-	-	-
Deferred Charges Long-Term	-	-	-	-	-
Total Assets	5.01M	2.02M	5.31M	12.21M	3.24M
Liabilities
Accounts Payable, Total	324K	520K	1.29M	279K	221K
Accrued Expenses, Total	25.44K	72.92K	57.77K	35.93K	65.13K
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	-	-	-	-	-
Other Current Liabilities	-	-	-	-	-
Total Current Liabilities	349K	593K	1.35M	315K	286K
Long-Term Debt	-	-	-	-	-
Other Non Current Liabilities	795K	-	-	-	-
Total Liabilities	1.14M	593K	1.35M	315K	286K
Common Stock, Total	25.75M	25.78M	34.35M	46.73M	48.91M
Retained Earnings	-25.33M	-28.7M	-36.43M	-41.56M	-52.16M
Comprehensive Income and Other	3.44M	4.35M	6.04M	6.72M	6.2M
Total Common Equity	3.86M	1.43M	3.96M	11.9M	2.95M
Total Equity	3.86M	1.43M	3.96M	11.9M	2.95M
Total Liabilities And Equity	5.01M	2.02M	5.31M	12.21M	3.24M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	697M	698M	874M	1.02B	1.05B
ECS Total Common Shares Outstanding	697M	698M	874M	1.02B	1.05B
Book Value / Share	0.01	0	0	0.01	0
Tangible Book Value	3.86M	1.43M	3.96M	11.9M	2.95M
Tangible Book Value Per Share	0.01	0	0	0.01	0
Total Debt	0	0	0	0	0
Net Debt	-4.83M	-1.9M	-5.03M	-11.63M	-3.03M
Account Code - Inventory Valuation	5	5	5	5	3
Inventories - Raw Materials, Total	-	-	-	-	-
Inventories - Finished Goods, Total	-	7.2K	7.78K	-	-
Buildings, Total	-	-	-	-	-
Machinery, Total	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	63.16K	-	-	-	-

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	-7.43M	-3.36M	-7.79M	-5.07M	-10.6M
Depreciation & Amortization - CF	-	-	1.74K	583	289
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	-	-	1.74K	583	289
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Provision for Credit Losses	-	-	-	-	-
Stock-Based Compensation (CF)	4.99M	83.96K	877K	2.18M	1.58M
Other Operating Activities, Total	-231K	-	-	-	-355K
Change In Accounts Receivable	-117K	43.47K	-158K	-60.49K	229K
Change In Inventories	-	-7.2K	-579	7.78K	-
Change In Accounts Payable	472K	244K	754K	-1.4M	-28.96K
Change in Other Net Operating Assets	-772	42.74K	1.42K	-253K	149K
Cash from Operations	-2.32M	-2.96M	-6.32M	-4.6M	-9.02M
Capital Expenditure	-	-3.2K	-	-	-
Sale of Property, Plant, and Equipment	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Cash from Investing	-	-3.2K	-	-	-
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-46.58K	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-46.58K	-	-	-	-
Issuance of Common Stock	7.62M	26.4K	9.45M	11.19M	430K
Other Financing Activities, Total	-443K	-	-	1	-
Cash from Financing	7.13M	26.4K	9.45M	11.19M	430K
Foreign Exchange Rate Adjustments	772	-	-	-	-
Miscellaneous Cash Flow Adjustments	-	1	-	-1	-
Net Change in Cash	4.82M	-2.93M	3.13M	6.6M	-8.59M
Supplemental Items
Cash Interest Paid	1.71K	1.37K	-	-	-
Cash Income Tax Paid (Refund)	-	-	-	-3.18M	-2.44M
Levered Free Cash Flow	-86.8K	-1.72M	-3.43M	-2.42M	-4.78M
Unlevered Free Cash Flow	-85.73K	-1.72M	-3.43M	-2.42M	-4.78M
Change In Net Working Capital	434K	-297K	-597K	1.34M	-349K
Net Debt Issued / Repaid	-46.58K	-	-	-	-

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	-182.56	-59.78	-133.86	-37.29	-86.84
Return on Total Capital	-284.04	-79.41	-182.02	-41.2	-90.35
Return On Equity %	-462.22	-127.08	-289.02	-63.92	-142.71
Return on Common Equity	-462.22	-127.08	-289.02	-63.92	-142.71
Margin Analysis
Gross Profit Margin %	109.02	94.4	100	99.75	100
SG&A Margin	1.03K	221.45	215.91	110.37	146.9
EBITDA Margin %	-	-553.11	-657.16	-164.5	-439.2
EBITA Margin %	-3.29K	-553.2	-657.31	-164.52	-439.21
EBIT Margin %	-3.29K	-553.2	-657.31	-164.52	-439.21
Income From Continuing Operations Margin %	-3.29K	-553.35	-652.32	-159.54	-433.6
Net Income Margin %	-3.29K	-553.35	-652.32	-159.54	-433.6
Net Avail. For Common Margin %	-3.29K	-553.35	-652.32	-159.54	-433.6
Normalized Net Income Margin	-2.06K	-345.84	-407.7	-99.72	-271
Levered Free Cash Flow Margin	-38.49	-283.7	-287.34	-76.24	-195.56
Unlevered Free Cash Flow Margin	-38.01	-283.56	-287.34	-76.24	-195.56
Asset Turnover
Asset Turnover	0.09	0.17	0.33	0.36	0.32
Fixed Assets Turnover	-	-	684.91	5.48K	-
Receivables Turnover (Average Receivables)	2.72	-	-	-	-
Inventory Turnover (Average Inventory)	-	-	-	-	-
Short Term Liquidity
Current Ratio	14.33	3.41	3.94	38.81	11.34
Quick Ratio	14.22	3.36	3.92	37.95	10.92
Operating Cash Flow to Current Liabilities	-6.63	-4.98	-4.69	-14.6	-31.58
Days Sales Outstanding (Average Receivables)	134.14	-	-	-	-
Days Outstanding Inventory (Average Inventory)	-	-	-	-	-
Average Days Payable Outstanding	-8.87K	-	-	-	-
Cash Conversion Cycle (Average Days)	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	-	-	-	-	-
Total Debt / Total Capital	-	-	-	-	-
LT Debt/Equity	-	-	-	-	-
Long-Term Debt / Total Capital	-	-	-	-	-
Total Liabilities / Total Assets	22.86	29.31	25.37	2.58	8.82
EBIT / Interest Expense	-4.35K	-2.46K	-	-	-
EBITDA / Interest Expense	-	-2.45K	-	-	-
(EBITDA - Capex) / Interest Expense	-	-2.46K	-	-	-
Total Debt / EBITDA	-	-	-	-	-
Net Debt / EBITDA	-	0.56	0.64	2.22	0.28
Total Debt / (EBITDA - Capex)	-	-	-	-	-
Net Debt / (EBITDA - Capex)	-	0.56	0.64	2.22	0.28
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	180.72	194.44	96.59	166	-23.07
Gross Profit, 1 Yr. Growth %	866.23	153	108.26	165.34	-22.88
EBITDA, 1 Yr. Growth %	-	-	133.57	-33.41	105.4
EBITA, 1 Yr. Growth %	475.22	-54.87	133.58	-33.42	105.38
EBIT, 1 Yr. Growth %	475.22	-54.87	133.58	-33.42	105.38
Earnings From Cont. Operations, 1 Yr. Growth %	333.67	-54.75	131.75	-34.94	109.08
Net Income, 1 Yr. Growth %	333.67	-54.75	131.75	-34.94	109.08
Normalized Net Income, 1 Yr. Growth %	333.67	-54.75	131.75	-34.94	109.08
Diluted EPS Before Extra, 1 Yr. Growth %	36.07	-68.04	102.32	-43.02	82.73
Accounts Receivable, 1 Yr. Growth %	1.55K	-	-	-	-
Inventory, 1 Yr. Growth %	-	-	8.04	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-66.68	-66.86	-
Total Assets, 1 Yr. Growth %	6.1K	-59.59	162.43	130.06	-73.47
Tangible Book Value, 1 Yr. Growth %	-697.48	-62.97	177.06	200.32	-75.17
Common Equity, 1 Yr. Growth %	-697.48	-62.97	177.06	200.32	-75.17
Cash From Operations, 1 Yr. Growth %	239.25	27.57	113.76	-27.25	96.38
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-71.85	1.65K	99.11	-29.42	97.34
Unlevered Free Cash Flow, 1 Yr. Growth %	96.8	1.66K	99.21	-29.42	97.34
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-4.22	175.01	140.59	128.67	43.05
Gross Profit, 2 Yr. CAGR %	9.87	374.76	129.54	135.07	43.05
EBITDA, 2 Yr. CAGR %	-	61.44	-	24.71	16.95
EBITA, 2 Yr. CAGR %	63.01	61.33	2.67	24.71	16.93
EBIT, 2 Yr. CAGR %	63.01	61.33	2.67	24.71	16.93
Earnings From Cont. Operations, 2 Yr. CAGR %	24.39	40.08	2.4	22.79	16.63
Net Income, 2 Yr. CAGR %	24.39	40.08	2.4	22.79	16.63
Normalized Net Income, 2 Yr. CAGR %	63.2	40.08	2.4	22.79	16.63
Diluted EPS Before Extra, 2 Yr. CAGR %	-39.04	-34.05	-19.58	7.37	2.42
Accounts Receivable, 2 Yr. CAGR %	796.62	-	-	-	-
Inventory, 2 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-	-66.77	-
Total Assets, 2 Yr. CAGR %	176.93	400.35	2.98	145.71	-21.87
Tangible Book Value, 2 Yr. CAGR %	260.33	48.75	1.29	188.46	-13.64
Common Equity, 2 Yr. CAGR %	260.33	48.75	1.29	188.46	-13.64
Cash From Operations, 2 Yr. CAGR %	-4.56	108.03	65.13	24.7	19.52
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	-76.4	136.44	489.45	18.54	18.02
Unlevered Free Cash Flow, 2 Yr. CAGR %	-76.54	528.88	492.66	18.57	18.02
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	95.8	35.21	145.89	148.78	59.04
Gross Profit, 3 Yr. CAGR %	62.79	41.22	260.73	140.9	62.13
EBITDA, 3 Yr. CAGR %	-	6.35	82.59	-	47.28
EBITA, 3 Yr. CAGR %	25.65	6.33	82.51	-11.13	47.27
EBIT, 3 Yr. CAGR %	25.6	6.33	82.51	-11.13	47.27
Earnings From Cont. Operations, 3 Yr. CAGR %	23.03	-11.2	65.68	-11.97	46.63
Net Income, 3 Yr. CAGR %	23.03	-11.2	65.68	-11.97	46.63
Normalized Net Income, 3 Yr. CAGR %	24.48	6.42	65.68	-11.97	46.63
Diluted EPS Before Extra, 3 Yr. CAGR %	-27.33	-50.84	-4.17	-28.31	28.51
Accounts Receivable, 3 Yr. CAGR %	90.3	-	-	-	-
Total Assets, 3 Yr. CAGR %	2.81	45.8	303.51	34.62	17
Tangible Book Value, 3 Yr. CAGR %	14.23	68.78	83.02	45.52	27.37
Common Equity, 3 Yr. CAGR %	-3	68.78	83.02	45.52	27.37
Cash From Operations, 3 Yr. CAGR %	-8.52	5.13	109.93	25.65	45.08
Levered Free Cash Flow, 3 Yr. CAGR %	-67.19	3.41	123.27	190.52	40.49
Unlevered Free Cash Flow, 3 Yr. CAGR %	-67.27	3.42	328.69	191.58	40.52
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.19	47.07	108.87	66.83	97.99
Gross Profit, 5 Yr. CAGR %	7.14	27.57	83.77	73.15	149.18
EBITDA, 5 Yr. CAGR %	-	-2.25	16.72	13.35	52.79
EBITA, 5 Yr. CAGR %	25.39	-2.87	15.96	13.33	52.74
EBIT, 5 Yr. CAGR %	25.37	-2.89	15.93	13.33	52.74
Earnings From Cont. Operations, 5 Yr. CAGR %	21.62	-3.57	14.32	1.09	43.97
Net Income, 5 Yr. CAGR %	21.62	-3.57	14.32	1.09	43.97
Normalized Net Income, 5 Yr. CAGR %	24.58	-2.97	15.13	12.69	43.97
Diluted EPS Before Extra, 5 Yr. CAGR %	-28.5	-38.28	-24.33	-32.81	-1.59
Accounts Receivable, 5 Yr. CAGR %	56.81	-	-	-	-
Inventory, 5 Yr. CAGR %	-	-38.33	-35.73	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-64.5	-70.25	-	-
Total Assets, 5 Yr. CAGR %	11.35	-16.39	2.88	79.65	109.23
Tangible Book Value, 5 Yr. CAGR %	48.23	-12.92	8.87	109.14	35.52
Common Equity, 5 Yr. CAGR %	21.28	-19.75	-1.31	109.14	35.52
Cash From Operations, 5 Yr. CAGR %	5.8	-1.09	15.86	12.56	67.58
Capital Expenditures, 5 Yr. CAGR %	-	-41.55	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	-9.54	6.91	9.22	73.01
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-9.38	7.02	9.24	155.9